FCGR3A and cancer: The immunohistochemical analysis revealed significantly higher expression of CD44, MYC, IL17A, CXCL1, FCGR3A, SPP1, and IL1A in cancer tissues, while CXCL12 and CCL5 showed significantly higher expression in adjacent normal tissues (Figure 7A–H and Figure S4).